Ascendis Pharma (ASND) Ownership - Who Owns Ascendis Pharma?

699 Followers

Ascendis Pharma (ASND) Ownership Overview

<0.01% Insiders

11.60% Mutual Funds

2.04% ETFs

86.36% Public Companies and

Individual Investors

The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. , <0.01% is owned by Insiders, and 86.36% is owned by Public Companies and Individual Investors.

The ownership structure of Ascendis Pharma (ASND) stock is a mix of institutional, retail, and individual investors. Approximately 13.64% of the company’s stock is owned by Institutional Investors, <0.01% is owned by Insiders, and 86.36% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
May 27, 2026	Jean Jacques Bienaime	xxxxxxxxxxxxx	$95118

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Mar 31, 2024	Perceptive Advisors Llc	xxxxxxxxxxxxx	$350281925
Mar 31, 2024	Woodline Partners Lp	xxxxxxxxxxxxx	$23437734
Mar 31, 2024	Driehaus Capital Management Llc	xxxxxxxxxxxxx	$29177256
Mar 31, 2024	Hussman Strategic Advisors Inc	xxxxxxxxxxxxx	$1921332

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
Peter Kolchinsky	10,281,496	Institution	16.48%	2,304,186,069
Joseph Edelman	1,531,421	Institution	2.46%	343,206,760
	1,279,738	Institution	2.05%	286,802,083
	1,103,469	Institution	1.77%	247,298,438
	965,222	Institution	1.55%	216,315,902
	740,625	Institution	1.19%	165,981,469
	664,000	Institution	1.06%	148,809,040
	531,184	Institution	0.85%	119,043,646
	439,726	Institution	0.70%	98,546,994
	359,029	Institution	0.58%	80,461,989

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,279,738	Institution	2.05%	286,802,083
1,103,469	Institution	1.77%	247,298,438
965,222	Institution	1.55%	216,315,902
740,625	Institution	1.19%	165,981,469
664,000	Institution	1.06%	148,809,040
531,184	Institution	0.85%	119,043,646
303,835	Institution	0.49%	68,092,462
254,766	Institution	0.41%	57,095,608
216,326	Institution	0.35%	48,480,820
214,582	Institution	0.34%	48,089,972

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
T. Rowe Price Capital Appreciation Equity ETF	336,525	Institution	0.54%	80,318,422
iShares Biotechnology ETF	336,023	Institution	0.54%	79,855,866
SPDR Portfolio Developed World ex-US ETF	60,463	Institution	0.10%	14,430,704
dbxt MSCI EM Shs -1C- Capitalisation	49,120	Institution	0.08%	11,723,470
Xtrackers MSCI Emerging Markets Swap UCITS ETF	49,120	Institution	0.08%	11,723,470
American Century Focused Dynamic Growth ETF	45,563	Institution	0.07%	10,421,625
iShares NASDAQ US Biotechnology UCITS ETF	43,979	Institution	0.07%	10,496,468
ARS Focused Opportunity Strategy ETF	38,897	Institution	0.06%	9,283,547
Invesco NASDAQ Next Gen 100 ETF	30,113	Institution	0.05%	7,156,354
Morgan Stanley Pathway Small-Mid Cap Equity ETF	29,581	Institution	0.05%	7,060,097

FAQ

Who Owns Ascendis Pharma A/S (ASND)?

Currently, no data Available

What percentage of Ascendis Pharma A/S (ASND) stock is held by institutional investors?

Currently, no data Available

What percentage of Ascendis Pharma A/S (ASND) stock is held by retail investors?

According to the latest TipRanks data, approximately 86.36% of Ascendis Pharma A/S (ASND) stock is held by retail investors.

Who owns the most shares of Ascendis Pharma A/S (ASND)?

Peter Kolchinsky owns the most shares of Ascendis Pharma A/S (ASND).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.